Tabel 4 nedenfor viser det skema, der er fulgt for andre doseringer i den kliniske undersøgelse af kombinationsbehandling med Caelyx og bortezomib af patienter med multipelt myelom.
Table 4, below provides the schedule followed for other dose modifications in the clinical trial in the treatment of patients with multiple myeloma receiving Caelyx and bortezomib combination therapy.